切换至 "中华医学电子期刊资源库"
高级检索
中华乳腺病杂志(电子版)

中华乳腺病杂志(电子版) ›› 2023, Vol. 17 ›› Issue (05) : 266 -271. doi: 10.3877/cma.j.issn.1674-0807.2023.05.002

论著

单孔非溶脂荧光腔镜技术在早期乳腺癌腋窝前哨淋巴结活组织检查中的应用
姚成才†(), 刘长春, 黄文剑, 陈明   
  1. 528225　佛山，华南理工大学附属第六医院乳腺外科
  • 收稿日期:2023-02-24 出版日期:2023-10-01
  • 通信作者: 姚成才
  • 基金资助:
    佛山市卫生和计生局医学科研立项课题(20190260); 佛山市高层次医学人才培养基金(2018B015); 佛山市"十四五"医学高水平重点专科建设项目(佛卫函〔2021〕107号)

Single-port non-lipolysis fluorescence-guided laparoscopy for axillary lymph node biopsy in early breast cancer

Chengcai Yao†(), Changchun Liu, Wenjian Huang, Ming Chen   

  1. Department of Breast Surgery, Sixth Affiliated Hospital of South China University of Technology, Foshan 528225, China
  • Received:2023-02-24 Published:2023-10-01
  • Corresponding author: Chengcai Yao
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

姚成才, 刘长春, 黄文剑, 陈明. 单孔非溶脂荧光腔镜技术在早期乳腺癌腋窝前哨淋巴结活组织检查中的应用[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 266-271.

Chengcai Yao, Changchun Liu, Wenjian Huang, Ming Chen. Single-port non-lipolysis fluorescence-guided laparoscopy for axillary lymph node biopsy in early breast cancer[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 266-271.

目的

探讨单孔非溶脂荧光腔镜技术在早期乳腺癌腋窝前哨淋巴结活组织检查(SLNB)中的应用效果。

方法

回顾性收集2020年6月至2022年5月华南理工大学附属第六医院乳腺外科收治的30例早期乳腺癌患者临床病理资料。所有患者均采用吲哚菁绿联合纳米碳双染法经胸外侧入路单孔非溶脂荧光腔镜行腋窝SLNB。采用t检验、χ2检验或Fisher确切概率法比较不同BMI组患者的手术相关指标及术后并发症。采用McNemar检验比较不同染色方法对前哨淋巴结(SLNs)的检出率，采用χ2检验比较检出淋巴结病理阳性率的差异。

结果

30例患者均顺利完成单孔非溶脂荧光腔镜腋窝SLNB。手术时间为(35.4±3.4) min。BMI >24.0 kg/m2的患者手术时间和腋窝总引流量均高于BMI为18.5~24.0 kg/m2的患者[(37.36±9.45) min比(30.29±6.15) min，t＝2.480，P＝0.019; (155.62±4.29) ml比(132.53±7.65)ml；t＝9.748，P<0.001]；而术中出血量、拔管时间及术后并发症比较，差异无统计学意义(t＝－0.869，P＝0.388；t＝1.193，P＝0.238；P＝1.000)。30例患者共检出SLNs 121枚，每例检出(4.89±1.73)枚，病理阳性SLNs 15枚，阳性率12.39%(15/121)。其中，发光SLNs 106枚，染色SLNs 88枚，吲哚菁绿和纳米碳的检出率分别为87.6%(106/121)和72.7%(88/121)，差异有统计学意义(P＝0.013)。106枚发光SLNs的病理阳性率为14.15%(15/106)；88枚染色SLNs的病理阳性率为14.77%(13/88)，二者差异无统计学意义(χ2＝0.015，P＝0.902)。30例患者中位随访15个月，无1例肿瘤局部复发或远处转移。

结论

单孔非溶脂荧光腔镜技术用于早期乳腺癌腋窝SLNB临床可行，并发症少，SLNs的检出率高，是一项适宜开展的临床新技术。

关键词: 乳腺肿瘤, 前哨淋巴结, 腹腔镜, 吲哚菁绿, 纳米碳
Objective

To investigate the application of single-port non-lipolysis fluorescence-guided laparoscopy in axillary sentinel lymph node biopsy (SLNB) of early breast cancer.

Methods

We retrospectively collected the clinicopathologic data of 30 early breast cancer patients in the Department of Breast Surgery, Sixth Affiliated Hospital of South China University of Technology from June 2020 to May 2022. They all underwent axillary SLNB by indocyanine green and nanocarbon staining and single-port non-lipolysis fluorescence-guided laparoscopy through the lateral thoracic approach. The surgical parameters and postoperative complications were compared using t test, χ2 test and Fisher exact test. The detection rates of sentinel lymph nodes (SLNs) were compared between different staining methods by McNemar test and the pathological positivity rates of detected lymph nodes were compared by χ2 test.

Results

All 30 patients successfully underwent axillary SLNB by single-port non-lipolysis fluorescence-guided laparoscopy. The operation time was (35.4±3.4) min. The operation time and total axillary drainage volume in patients with BMI >24.0 kg/m2 were significantly higher compared with the patients with BMI of 18.5~24.0 kg/m2[(37.36±9.45) min vs (30.29±6.15) min, t=2.480, P=0.019; (155.62±4.29) ml vs(132.53±7.65)ml; t=9.748, P<0.001]. There was no significant difference in intraoperative blood loss, extubation time and postoperative complications (t=-0.869, P=0.388; t=1.193, P=0.238; P=1.000). A total of 121 SLNs were detected in 30 patients, (4.89±1.73) nodes per person. Fifteen nodes were confirmed as pathologically positive SLNs(12.39%, 15/121). Among 121 detected SLNs, 106 were luminescent (indocyanine green-positive) and and 88 were stained (nanocarbon positive); the detection rates of two methods were 87.6% (106/121) and 72.7% (88/121), respectively, indicating a significant difference (P=0.013). Fifteen nodes were pathologically positive out of 106 luminescent SLNs, with a positive rate of 14.15% (15/106); 13 nodes were pathologically positive out of 88 stained SLNs, with a positive rate of 14.77% (13/88); there was no significant difference between the two (χ2=4.081, P=0.130). All 30 patients were followed up for median 15 months, and no recurrence or distant metastasis of breast cancer was observed.

Conclusion

Single-port non-lipolysis fluorescence-guided laparoscopy for axillary SLNB of early breast cancer is clinically feasible, with few complications and high detection rate of SLNs, worth of clinical application.

Key words: Breast neoplasms, Sentinel lymph nodes, Laparoscopy, Indocyanine green, Carbon nanoparticles
表1 30例早期乳腺癌患者的临床病理特征
临床病理特征 例数
月经状况  
未绝经 18
已绝经 12
体质指数  
18.5~24.0 kg/m2 17
>24.0 kg/m2 13
肿瘤长径  
≤2 cm 14
>2 cm且≤3 cm 16
病理类型  
浸润性导管癌 28
非浸润性导管癌 2
TNM分期  
Ⅰ期 14
ⅡA期 16
分子分型  
Luminal型 15
HER-2过表达型 10
三阴型 5
图1 单孔非溶脂近红外荧光腔镜腋窝前哨淋巴结活组织检查　a图所示荧光脉管成像仪显示乳腺皮下荧光的淋巴管(蓝色箭头)；b图所示高清近红外荧光腔镜显示乳腺皮下荧光的淋巴管(蓝色箭头)；c图所示经胸外侧腋中线手术入路置入单孔腔镜牵开器进行手术操作；d图所示近红外荧光腔镜荧光模式下显示荧光的淋巴管(蓝色箭头)；e图所示荧光模式下显示发光SLN(蓝色箭头)、单纯染色-SLN(黑色箭头)和N-SLNs(红色箭头)；f图所示术中切除的淋巴结(1、2为既发光又染色的SLNs，3、5为单纯发光SLNs，4为单纯染色SLNs)注：SLNs为前哨淋巴结，N-SLNs为非前哨淋巴结
表2 30例早期乳腺癌患者手术指标及术后并发症与体质指数的关系
体质指数 例数 手术时间(min) 术中出血量(ml) 总引流量(ml) 腋窝拔管时间(d) 术后并发症(例)
切口愈合不良 患侧上肢水肿
>24.0 kg/m2 13 37.36±9.45 5.13±3.78 155.62±4.29 5.16±1.95 2 0
18.5~24.0 kg/m2 17 30.29±6.15 5.76±1.23 132.53±7.65 4.61±1.63 1 1
t值   2.480 －0.869 9.748 1.193    
P值   0.019 0.388 <0.001 0.238 1.000a
表3 采用吲哚菁绿荧光和纳米碳染色法检出的121枚SLNs的分布情况(枚)
纳米碳染色法 荧光法 合计
发光SLNs 非发光SLNs
染色SLNs 73 15 88
非染色SLNs 33 0 33
合计 106 15 121
[1]
Luo CY, Zhang J, Lin H, et al. Mastoscopic axillary lymph node dissection for the patients with breast cancer[J]. Zhonghua Yi Xue Za Zhi, 2003, 83(22)：1946-1948.
[2]
Guo MQ, Jiang J, Yang XH, et al. Technique investigation of endoscopic axillary lymph node dissection by liposuction[J]. Zhonghua Wai Ke Za Zhi, 2006, 44(11)：757-761.
[3]
Shi F, Huang Z, Yu J, et al. Immediate liposuction could shorten the time for endoscopic axillary lymphadenectomy in breast cancer patients[J]. World J Surg Oncol, 2017, 15(1)：35-41
[4]
Chengyu L, Yongqiao Z, Hua L, et al. A standardized surgical technique for mastoscopic axillary lymph node dissection[J]．Surg Laparosc Endosc Percutan Tech, 2005，15(3)：153-159.
[5]
Bonin EA, Mariani A, Swain J, et al. Laparoscopic ultrasound-assisted liposuction for lymph node dissection: a pilot study[J]. Surg Endosc，2012，26(7)：1963-1970.
[6]
Voulliaume D, Vasseur C, Delaporte T, et al. An unusual risk of liposuction: liposuction of a malignant tumor. About 2 patients[J]. Ann Chir Plast Esthet，2003，48(3)：187-193.
[7]
杨为戈，倪小健．乳腺癌腔镜腋窝淋巴结清扫手术方式选择及评价[J]．中国实用外科杂志，2020，40(10)：1143-1146.
[8]
Liang Y, Xu S. Nonliposuction endoscopic sentinel lymph node biopsy through the periareolar incision[J]. Surg Innov，2020，27(6)：570-579.
[9]
Fang J, Ma L, Zhang YH, et al. Endoscopic sentinel lymph node biopsy and endoscopic axillary lymphadenectomy without liposuction in patients with early stage breast cancer[J]. Surg Oncol，2017，26(4)：338-344.
[10]
Wang Z，Cui Y，Zheng M，et al. Comparison of indocyanine green fluorescence and methylene blue dye in the detection of sentinel lymph nodes in breast cancer[J]. Gland Surg，2020，9(5)：1495-1501.
[11]
Yang P, Hu X, Peng S, et al. Near-infrared laparoscopy with indocyanine green for axillary sentinel lymph node biopsy in early breast cancer: preliminary experience of a single unit[J]. Gland Surg, 2021，10(5)：1677-1686.
[12]
姚成才，陈明，黄传蔷等．吲哚氰绿联合亚甲蓝或纳米碳在乳腺癌新辅助化疗后前哨淋巴结活检中的效果比较[J]．广东医学，2021，42(S)：25-28.
[13]
中国抗癌协会乳腺癌专业委员会．中国抗癌协会乳腺癌专业指南和规范(2017年版)[J]．中国癌症杂志，2017，27(9)：695-760.
[14]
Ogura K, Yakoub MA, Christ AB, et al. The critical difference in the DASH (Disabilities of the Arm，Shoulder, and Hand) outcome measure after essential upper extremity tumor surgery[J]. J Shoulder Elbow Surg. 2021；30(9)：e602-e609.
[15]
Huang L, Lin YH, Yang Y, et al. Comparative analysis of vaginal natural orifice transluminal endoscopic surgery versus transumbilical laparoendoscopic single-site surgery in ovarian cystectomy[J]. J Obstet Gynaecol Res，2021，47(2)：757-764.
[16]
Dietrich CG, Schoppmeyer K. Percutaneous endoscopic gastrostomy--Too often? Too late? Who are the right patients for gastrostomy? [J]. World J Gastroenterol, 2020, 26(20)：2464-2471.
[17]
Tsukamoto M, Imai K, Yamashita YI, et al. Endoscopic hepatic resection and endoscopic radiofrequency ablation as initial treatments for hepatocellular carcinoma within the Milan criteria[J]. Surg Today，2020，50(4)：402-412.
[18]
Yoshihiro G, Takagi S, Yanagisawa J, et al. Endoscopic internal thoracic artery harvesting with changes in scope position[J]. Heart Surg Forum，2021，24(6)：E950-E951.
[19]
Kobayashi Y, Nishikawa K, Akasaka T, et al. Retrograde endoscopic submucosal dissection for early thoracic esophageal carcinoma[J]. Clin J Gastroenterol，2021，14(2)：434-438.
[20]
Akritidou E, Douridas G, Spartalis E, et al. Complications of trans-oral endoscopic thyroidectomy vestibular approach: a systematic review[J]. In Vivo, 2022，36(1)：1-12.
[21]
Yang Y, Mu D, Xu B, et al. Endoscopic subcutaneous mastectomy plus liposuction via a single axillary incision for gynecomastia in Asian patients: a report of 45 cases[J]. Surgery, 2021，170(1)：39-46.
[22]
Chen Y, Xu J, Liang Y, et al. A challenging therapeutic method for breast cancer: non-lipolytic endoscopic axillary surgery through periareolar incisions[J]. Oncol Lett，2020，19(6)：4088-4092.
[23]
Lai HW, Mok CW, Chang YT, et al. Endoscopic assisted breast conserving surgery for breast cancer: clinical outcome, learning curve，and patient reported aesthetic results from preliminary 100 procedures[J]. Eur J Surg Oncol，2020，46(8)：1446-1455.
[24]
Jeon DN, Kim J, Ko BS, et al. Robot-assisted breast reconstruction using the prepectoral anterior tenting method[J]. J Plast Reconstr Aesthet Surg，2021，74(11)：2906-2915.
[25]
Chen K, Zhang J, Beeraka NM，et al. Robot-Assisted Minimally Invasive Breast Surgery: Recent Evidence with Comparative Clinical Outcomes[J]. J Clin Med，2022，11(7)：1827.
[26]
Xiong H, Chen Z, Xu L, et al. Contrast of mastoscopic and conventional axillary lymph node dissection of patients with breast cancer: meta-analysis[J]. Cancer Control, 2020，27(2)：1073274820932987.
[27]
Ye JM, Guo BL, Liu Q, et al. Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021[J]. Chin Med J (Engl)，2021，134(8)：886-894.
[28]
Langer I, Kocher T, Guller U, et al. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients[J]. Breast Cancer Res Treat, 2005，90(1)：85-91.
[29]
Luo C, Wei C, Guo W, et al. 17-year follow-up of comparing mastoscopic and conventional axillary dissection in breast cancer: a multicenter, randomized controlled trial[J]. Adv Ther, 2022, 39(6)：2961-2970.
[1] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志（电子版）, 2023, 20(08): 844-848.
[2] 邵华, 那子悦, 荆慧, 李博, 王秋程, 程文. 术前经皮超声造影对乳腺癌腋窝前哨淋巴结转移及负荷的诊断价值[J]. 中华医学超声杂志（电子版）, 2023, 20(08): 849-853.
[3] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[4] 李凯, 陈淋, 向涵, 苏怀东, 张伟. 一种U型记忆合金线在经脐单孔腹腔镜阑尾切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 15-15.
[5] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[6] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[7] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[8] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[9] 李晓玉, 江庆, 汤海琴, 罗静枝. 围手术期综合管理对胆总管结石并急性胆管炎患者ERCP +LC术后心肌损伤的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 57-60.
[10] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[11] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[12] 李三祥, 李佳, 刘俊峰, 吕东晨, 方晖东, 谭朝晖, 刘杰, 潘佐, 乔建坤. 基于CT影像的三维重建成像技术在腹腔镜大肾上腺肿瘤切除术中的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 570-574.
[13] 赵佳晖, 王永兴, 彭涛, 李明川, 魏德超, 韩毅力, 侯铸, 姜永光, 罗勇. 后腹腔镜根治性肾切除手术时间延长和术中出血量增多的影响因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 575-580.
[14] 林文斌, 郑泽源, 郑文能, 郁毅刚. 外伤性脾破裂腹腔镜脾切除术患者中转开腹风险预测模型构建[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 619-623.
[15] 牛朝, 李波, 张万福, 靳文帝, 王春晓, 李晓刚. 腹腔镜袖状胃切除联合胆囊切除治疗肥胖合并胆囊结石安全性和疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 635-639.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号